Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCAP.L Regulatory News (FCAP)

  • There is currently no data for FCAP

Trading Update

10 Mar 2022 07:00

RNS Number : 2723E
finnCap Group PLC
10 March 2022
 

10 March 2022

 

finnCap Group PLC

Trading Update

FY 22 Revenues to exceed £45-£50m guidance range

 

finnCap Group PLC ("finnCap" or the "Company" or the "Group"), a leading provider of strategic advisory and capital raising services to growth companies, is pleased to confirm that unaudited revenue for the year to date has now exceeded the top end of its £45-£50m guidance range.

 

 

 

 

 

 

Sam Smith, CEO commented:

"With further potential deals to close, the Group is set to deliver record revenue for FY22. We have seen the real benefits of diversifying our products and customer base with a particularly good performance in ECM in complex markets and another strong half year in M&A."

 Contacts:

finnCap Group plc Tel: +44 (0) 20 7220 0500

Sam Smith, Chief Executive OfficerRichard Snow, Chief Financial Officer

Grant Thornton (Nominated Adviser) Tel: +44 (0) 20 7383 5100

Philip Secrett/Samantha Harrison/George Grainger 

Oberon Capital (Joint Broker) Tel: +44 (0) 20 3179 5344

Mike Seabrook

finnCap Ltd (Joint Broker) Tel: +44 (0) 20 7220 0500

Rhys Williams/Tim Redfern

 Hudson Sandler (PR Adviser) Tel: +44 (0) 20 7796 4133

Dan de Belder/Rebekah Chapman

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

About finnCap

finnCap Group provides strategic advice, capital raising and related services to corporate and institutional clients and high net worth investors including private equity and family offices. Established in 2007 the Group has built a strong track record in equity advice and fund-raisings, public and private M&A, debt arrangement and advice and act as NOMAD for clients listed on AIM with a particular focus on the technology, life sciences, consumer and business services sectors.

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKUURUWUORUR
Date   Source Headline
1st Jun 20217:00 amRNSBlock Admission Return and Total Voting Rights
13th May 20217:00 amRNSDirector Dealing, Option Exercise & TVR
30th Apr 20217:00 amRNSTotal Voting Rights
8th Apr 202111:06 amRNSSecond Price Monitoring Extn
8th Apr 202111:00 amRNSPrice Monitoring Extension
7th Apr 20217:00 amRNSFY21 Unaudited Total Income - Strong end to FY21
1st Apr 20217:00 amRNSTotal Voting Rights
5th Mar 20219:16 amRNSDirectors’ Dealings
3rd Mar 20214:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:35 pmRNSPrice Monitoring Extension
3rd Mar 20211:55 pmRNSFY21 Trading Update
1st Mar 20217:00 amRNSTotal Voting Rights
23rd Feb 20217:00 amRNSAppointment of Broker
1st Feb 20217:00 amRNSTotal Voting Rights
4th Jan 20217:00 amRNSTotal Voting Rights
4th Dec 20207:00 amRNSDirector/PDMR Shareholding
1st Dec 20207:00 amRNSBlock Admission Return and Total Voting Rights
18th Nov 202010:54 amRNSDirector/PDMR Shareholding
18th Nov 20207:00 amRNSBoard Changes
18th Nov 20207:00 amRNSInterim Results and Interim Dividend
30th Oct 20207:00 amRNSTotal Voting Rights
1st Oct 20207:00 amRNSTotal Voting Rights
21st Sep 20202:12 pmRNSResult of AGM
21st Sep 20207:00 amRNSAGM Trading Statement
3rd Sep 20209:12 amRNSOption Exercise - Director/PDMR Shareholding
1st Sep 202011:40 amRNSTotal Voting Rights- Replacement
1st Sep 20207:00 amRNSTotal Voting Rights
17th Aug 20207:00 amRNSAdditional Block Admission of Shares
13th Aug 202012:30 pmRNSOption Grant
31st Jul 202010:18 amRNSAnnual Report and Annual General Meeting Notice
31st Jul 20207:00 amRNSTotal Voting Rights
7th Jul 20207:00 amRNSPreliminary results - year ended 31 March 2020
1st Jul 20207:00 amRNSTotal Voting Rights
16th Jun 20208:56 amRNSChange of Registered Office
1st Jun 20207:00 amRNSBlock Admission Return and Total Voting Rights
26th May 202010:20 amRNSDirector/PDMR Shareholding
26th May 20207:00 amRNSProperty Financing
20th May 20207:00 amRNSDirectorate Changes
6th May 20209:54 amRNSDirector’s Dealing and Concert Party Update
1st May 20207:00 amRNSTotal Voting Rights
2nd Apr 20207:00 amRNSOption Surrenders and Grants
1st Apr 20203:11 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSTrading Update
12th Mar 20201:44 pmRNSHolding(s) in Company
4th Mar 20207:00 amRNSTotal Voting Rights
27th Feb 20207:00 amRNSTrading Update
14th Feb 20207:00 amRNSNew Director Appointment
4th Feb 20207:00 amRNSTotal Voting Rights
23rd Jan 20203:32 pmRNSDirector/PDMR Shareholding
17th Jan 20202:52 pmRNSSigning of new lease to consolidate premises

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.